Acadia Pharmaceuticals ACAD FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Acadia Pharmaceuticals's FX effect on cash?
- Acadia Pharmaceuticals (ACAD) reported FX effect on cash of $25K in Q1 2026.
- How has Acadia Pharmaceuticals's FX effect on cash changed year-over-year?
- Acadia Pharmaceuticals's FX effect on cash increased by 600.0% year-over-year, from -$5K to $25K.
- What is the long-term trend for Acadia Pharmaceuticals's FX effect on cash?
- Over 2 years (2023 to 2025), Acadia Pharmaceuticals's FX effect on cash has grown at a 20.2% compound annual growth rate (CAGR), from -$18K to $26K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.